The Story behind the Science: Solving the riddle for the pathogenesis of vulvovaginal candidiasis.

Vulvovaginal candidiasis (VVC) is caused by an immunopathogenic response involving dysfunctional neutrophils, overturning previous beliefs about adaptive immunity's role.

• Why it matters: Understanding VVC's true mechanism is crucial because it has remained a mystery for nearly 30 years, hindering effective treatments and prevention strategies.
• What they did: Researchers conducted clinical studies, animal models, and a pioneering live Candida challenge trial, revealing that VVC results from an exaggerated neutrophil response rather than immune deficiency.
• The result: This discovery redefines VVC as an immunopathogenic condition, paving the way for targeted therapies that modulate neutrophil activity and improve patient outcomes.